bepmed |

9739624
l 1997
WO

161. DIFFUSION GRADIENT BIOREACTOR AND EXTRACORPOREAL LIVER DEVICE

Abstract

A tissue engineering bioreactor is disclosed for growing three-dimensional tissue. Cells are seeded onto a mesh and provided with two media flows, each contacting a...

14:01 / cells / system

95107606
l 1997
RU

162. KERATOPROSTHESIS

Abstract

FIELD: ophthalmology, replacement of eye cornea affected with opacities of different etiologies. SUBSTANCE: optical part of proposed keratoprosthesis is made in form of lens formed...

14:01 / rest

2266581
l 1998
CA

163. POLYMERS CONTAINING POLYSACCHARIDES SUCH AS ALGINATES OR MODIFIED ALGINATES

Abstract

Materials which contain polysaccharide chains, particularly alginate or modified alginate chains. The polysaccharide chains may be included as side chains or auxiliary chains from a...

14:01 / methods / Scaffolds

7595698
l 1998
AU

164. Semi-interpenetrating or interpenetrating polymer networks for drug delivery andtissue engineering

Abstract

Year: 1998 Country: AU Doc No: 7595698 For more information visit espacenet.com Read more...

14:01 / methods / Scaffolds

5681730
l 1997
US

165. Particle-mediated transformation of gymnosperms

Abstract

A method for genetically engineering gymnosperm tree species is based on accelerated particle transformation. Tissue of spruce is cultured into an embryogenic callus. Somatic embryos...

14:01 / methods / system

9705198
l 1997
MX

166. COLLAGEN-BASED METHODS AND FORMULATIONS FOR THE TREATMENT OF IMMUNE SYSTEM-MEDIATED DISEASES.

Abstract

The invention provides novel methods and compositions for the treatment of immune system-mediated diseases, including rheumatoid arthritis. The subject compositions comprise one or more different...

14:01 / methods

5610241
l 1997
US

167. Reactive graft polymer with biodegradable polymer backbone and method for preparing reactive biodegradable polymers

Abstract

Graft polymers with reactive groups for linking to peptides for use in tissue engineering and to drugs to provide drug delivery systems and useful per...

14:01 / methods / Scaffolds

H10203995
l 1998
JP

168. ANTI-OSTEOPOROTIC AGENT

Abstract

PROBLEM TO BE SOLVED: To obtain an oral therapeutic agent capable of treating and preventing osteoporosis by incorporating collagen I as active ingredient. SOLUTION: This...

14:00 / Biomaterial / methods

1194306
l 1998
CN

169. Establish ment of yeast engineering fungus for secreting expression tissue type plasminogen activator

Abstract

Tissue-type plasminogen activator cDNA with modified 5' end is placed into yeast expression carrier pY-18 with alpha mating factor signal peptide series to obtain male...

14:00 / methods / system

H1052278
l 1998
JP

170. PRODUCTION OF FUNCTIONAL POLYPEPTIDE

Abstract

PROBLEM TO BE SOLVED: To obtain a new transformant containing a recombinant plasmid coding for a functional polypeptide expressed by a specific amino acid sequence...

14:00 / cells / methods

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract